High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials

Bo Liang1, Ning Gu2

  • 1Nanjing University of Chinese Medicine, Nanjing, China.

Insights

High-speed rotational atherectomy (RA) improves strategy success for coronary artery calcification (CAC) lesion preparation. While RA shows excellent 9-month clinical outcomes, it is linked to increased in-stent late lumen loss and longer procedure times.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Coronary artery calcification (CAC) poses challenges for percutaneous coronary intervention.
  • High-speed rotational atherectomy (RA) is a technique used to optimize lesion preparation in calcified coronary lesions.
  • Previous trials have investigated the clinical outcomes of RA in CAC.

Purpose of the Study:

  • To evaluate the safety and efficacy of RA for lesion preparation in patients with CAC.
  • To compare the outcomes of RA versus conventional methods for treating calcified coronary lesions.

Main Methods:

  • A pooled analysis of patient data from the ROTAXUS and PREPARE-CALC trials was performed.
  • The study included 440 patients, randomized into RA and control groups (220 each).
  • Primary endpoints included in-stent late lumen loss and major adverse cardiac events at 9 months. Secondary endpoints comprised in-segment late lumen loss, binary restenosis, strategy success, procedural duration, and contrast volume.

Main Results:

  • The RA group demonstrated significantly higher strategy success rates (95.0% vs. 82.3%, p < 0.0001) with fewer crossovers compared to the control group (2.3% vs. 14.1%, p < 0.0001).
  • In-stent late lumen loss was higher in the RA group (0.34 ± 0.52 mm vs. 0.24 ± 0.47 mm, p = 0.03), and procedural duration was longer (76.3 ± 41.8 min vs. 67.0 ± 38.8 min, p = 0.02).
  • Major adverse cardiac events (17.8% vs. 25.2%, p = 0.06) and in-segment late lumen loss (0.28 ± 0.66 mm vs. 0.17 ± 0.55 mm, p = 0.05) were comparable between groups, with no significant difference in binary restenosis or contrast volume.

Conclusions:

  • Upfront RA is a feasible strategy for lesion preparation in CAC prior to drug-eluting stent implantation.
  • RA is associated with improved strategy success and excellent 9-month clinical outcomes.
  • The benefits of RA must be weighed against increased in-stent late lumen loss and longer procedural duration.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
44
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
148
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
58
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
56